The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants

Reproductive Toxicology

Volumn 30, Issue 1, 2010, Pages 200-218

  Schenk, Barbara ^a   Weimer, Marc ^b   Bremer, Susanne ^c   van der Burg, Bart ^d   Cortvrindt, Rita ^e   Freyberger, Alexius ^f   Lazzari, Giovanna ^g   Pellizzer, Cristian ^c   Piersma, Aldert ^h   Schäfer, Wolfgang R ⁱ   Seiler, Andrea ^j   Witters, Hilda ^k   Schwarz, Michael ^a  

^a Institute of Experimental and Clinical Pharmacology and Toxicology   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c JOINT RESEARCH CENTRE   (Italy)

^d BIODETECTION SYSTEMS B V   (Netherlands)

^e EggCentris NV   (Belgium)

^f BAYER PHARMA AG   (Germany)

^g Laboratorio di Tecnologie della Riproduzione   (Italy)

^h NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^k FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

more..

Author keywords

Alternative reproductive toxicity testing; Embryotoxicity; Endocrine disruption; Fertility; In vitro tests; Ring trial

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CADMIUM CHLORIDE; CARBENDAZIM; CHEMICAL COMPOUND; METHOXYACETIC ACID; METHYLACETOACETATE; NITROBENZENE; NITROFEN; PHOSPHINOTHRICIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VINCLOZOLIN; ENDOCRINE DISRUPTOR;

ACCURACY; ARTICLE; ASSAY; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); EMBRYO DEVELOPMENT; FEASIBILITY STUDY; FERTILITY; IN VITRO STUDY; IN VIVO STUDY; PREDICTION; REPRODUCTIVE TOXICITY; REPROTECT FEASIBILITY STUDY; TOXICITY TESTING; TOXIN ANALYSIS; ANIMAL; ANIMAL TESTING ALTERNATIVE; BIOASSAY; DOSE RESPONSE; DRUG EFFECTS; PROCEDURES; REPRODUCTION; STANDARDS; STATISTICS AND NUMERICAL DATA; TOXICITY;

ANIMAL TESTING ALTERNATIVES; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYONIC DEVELOPMENT; ENDOCRINE DISRUPTORS; ENDPOINT DETERMINATION; FEASIBILITY STUDIES; FERTILITY; REPRODUCTION; IN VITRO TECHNIQUES;

ANIMALIA;

EID: 77954086651     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.05.012     Document Type: Article

References (165)

1. Pazos P., Pellizzer C., Stummann T.C., Hareng L., Bremer S. The test chemical selection procedure of the European Centre for the validation of alternative methods for the ReProTect integrated project. Reprod Toxicol 2010, 30(1):161-199.
2. Freyberger A., Weimer M., Tran H.S., Ahr H.J. Assessment of a recombinant androgen receptor binding assay initial steps towards validation. Reprod Toxicol 2010, 30(1):2-8.
3. Van der Burg B., Winter R., Man H.-Y., Vangenechten C., Weimer M., Berckmans P., et al. Optimization and prevalidation of the in vitro AR CALUX method to test androgenis and antiandrogenic activity of compounds. Reprod Toxicol 2010, 30(1):18-24.
4. Sonneveld E., Jansen H.J., Riteco J.A., Brouwer A., van der Burg B. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicol Sci 2005, 83(1):136-148.
5. Freyberger A., Witters H., Weimer M., Lofink W., Berckmans P., Ahr H.J. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation. Reprod Toxicol 2010, 30(1):9-17.
6. Freyberger A., Wilson V., Weimer M., Tan S., Tran H.S., Ahr H.J. Assessment of a robust model protocol with accelerated throughput for a human recombinant full length estrogen receptor-alpha binding assay: protocol optimization and intralaboratory assay performance as initial steps towards validation. Reprod Toxicol 2010, 30(1):50-59.
7. Van der Burg B., Winter R., Weimer M., Berckmans P., Suzuki G., Gijsbers L., et al. Optimization and prevalidation of the in vitro ERα CALUX method to test estrogenic and antiestrogenic activity of compounds. Reprod Toxicol 2010, 30(1):73-80.
8. Berckmans P., Leppens H., Vangenechten C., Witters H. Screening of endocrine disrupting chemicals with MELN cells, an ER-transactivation assay combined with cytotoxicity assessment. Toxicol In Vitro 2007, 21(7):1262-1267.
9. Witters H., Freyberger A., Smits K., Vangenechten C., Lofink W., Weimer M., et al. The assessment of estrogenic or anti-estrogenic activity of chemicals by the human stably transfected estrogen sensitive MELN cell line: results of test performance and transferability. Reprod Toxicol 2010, 30(1):60-72.
10. Cortvrindt R.G., Smitz J.E. Follicle culture in reproductive toxicology: a tool for in-vitro testing of ovarian function?. Hum Reprod Update 2002, 8(3):243-254.
11. Van Wemmel K., Gobbers E., Eichenlaub-Ritter U., Smitz J., Cortvrindt R. Ovarian follicle bioassay reveals adverse effects of diazepam exposure upon follicle development and oocyte quality. Reprod Toxicol 2005, 20(2):183-193.
12. Devine P.J. Cortvrindt. In vitro ovarian model systems 2010, Elsevier Ltd. 2nd ed.
13. Lazzari G., Tessaro I., Crotti G., Galli C., Hoffmann S., Bremer S., et al. Development of an in vitro test battery for assessing chemical effects on bovine germ cells under the ReProTect umbrella. Toxicol Appl Pharmacol 2008, 233(3):360-370.
14. Luciano A.M., Franciosi F., Lodde V., Corbani D., Lazzari G., Crotti G., et al. Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte maturation (IVM) test within ReProTect. Reprod Toxicol 2010, 30(1):81-88.
15. Lemeire K., Van Merris V., Cortvrindt R. The antibiotic streptomycin assessed in a battery of in vitro tests for reproductive toxicology. Toxicol In Vitro 2007, 21(7):1348-1353.
16. Van Merris V., Van Wemmel K., Cortvrindt R. In vitro effects of dexamethasone on mouse ovarian function and pre-implantation embryo development. Reprod Toxicol 2007, 23(1):32-41.
17. Schaefer W.R., Fischer L., Deppert W.R., Hanjalic-Beck A.L.S., Weimer M., et al. In vitro-Ishikawa cell test for assessing tissue-specific chemical effects on human endometrium. Reprod Toxicol 2010, 30(1):89-93.
18. Piersma A.H., Genschow E., Verhoef A., Spanjersberg M.Q., Brown N.A., Brady M., et al. Validation of the postimplantation rat whole-embryo culture test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim 2004, 32(3):275-307.
19. Seiler A.E., Buesen R., Visan A., Spielmann H. Use of murine embryonic stem cells in embryotoxicity assays: the embryonic stem cell test. Methods Mol Biol 2006, 329:371-395.
20. Genschow E., Spielmann H., Scholz G., Pohl I., Seiler A., Clemann N., et al. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim 2004, 32(3):209-244.
21. Uibel F., Muhleisen A., Kohle C., Weimer M., Stummann T.C., Bremer S., et al. ReProGlo: a new stem cell based reporter assay aimed to predict embryotoxic potential of drugs and chemicals. Reprod Toxicol 2010, 30(1):103-112.
22. Team RDC. R: A language and environment for statistical computing. Vienna, Austria; 2009.
23. Marx-Stoelting P., Adriaens E., Ahr H.J., Bremer S., Garthoff B., Gelbke H.P., et al. A review of the implementation of the embryonic stem cell test (EST). The report and recommendations of an ECVAM/ReProTect Workshop. Altern Lab Anim 2009, 37(3):313-328.
24. EU. Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006. Official J EU 2008;L 353:1-1355.
25. Izumi HKE, Yuki K, Chijiwa T, Kuwasaki E, Ichiki T. Combined repeat. dose and reproductive/developmental toxicity screening test of methyl acetoacetate by oral administration in rats. Year not given. Available from: [cited November 2010]. http://dra4.nihs.go.jp/mhlw_data/home/paper/paper105-45-3d.html.
26. Schulte-Hermann R., Wogan G.N., Berry C., Brown N.A., Czeizel A., Giavini E., et al. Analysis of reproductive toxicity and classification of glufosinate-ammonium. Regul Toxicol Pharmacol 2006, 44(3 Suppl 1):1-76.
27. Ebert E., Leist K.H., Mayer D. Summary of safety evaluation toxicity studies of glufosinate ammonium. Food Chem Toxicol 1990, 28(5):339-349.
28. Fujii T. Transgenerational effects of maternal exposure to chemicals on the functional development of the brain in the offspring. Cancer Causes Control 1997, 8(3):524-528.
29. Jansen M.S., Nagel S.C., Miranda P.J., Lobenhofer E.K., Afshari C.A., McDonnell D.P. Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. Proc Natl Acad Sci USA 2004, 101(118):7199-7204.
30. Wade M.G., Kawata A., Williams A., Yauk C. Methoxyacetic acid-induced spermatocyte death is associated with histone hyperacetylation in rats. Biol Reprod 2008, 78(5):822-831.
31. Bagchi G., Waxman D.J. Toxicity of ethylene glycol monomethyl ether: impact on testicular gene expression. Int J Androl 2008, 31(2):269-274.
32. Lamb J.C., George J.D., Reel J.R., Myers C.B., Lawton A.D. Methoxyacetic acid. Environ Health Perspect 1997, 105(Suppl 1):227-228.
33. Foster P.M., Creasy D.M., Foster J.R., Gray T.J. Testicular toxicity produced by ethylene glycol monomethyl and monoethyl ethers in the rat. Environ Health Perspect 1984, 57:207-217.
34. Khera K.S. Mouse placenta: hemodynamics in the main maternal vessel and histopathologic changes induced by 2-methoxyethanol and 2-methoxyacetic acid following maternal dosing. Teratology 1993, 47(4):299-310.
35. Ritter E.J., Scott W.J., Randall J.L., Ritter J.M. Teratogenicity of dimethoxyethyl phthalate and its metabolites methoxyethanol and methoxyacetic acid in the rat. Teratology 1985, 32(1):25-31.
36. Rasjad C., Yamashita K., Datu A.R., Yasuda M. Pattern of limb malformations in mice induced by methoxyacetic acid. Hiroshima J Med Sci 1991, 40(3):93-99.
37. Rasjad C., Yamashita K., Datu A.R., Yasuda M. Pathogenesis of limb malformations in mice induced by methoxyacetic acid. Hiroshima J Med Sci 1991, 40(3):101-107.
38. Welsch F., Sleet R.B., Greene J.A. Attenuation of 2-methoxyethanol and methoxyacetic acid-induced digit malformations in mice by simple physiological compounds: implications for the role of further metabolism of methoxyacetic acid in developmental toxicity. J Biochem Toxicol 1987, 2:225-240.
39. Grollman A., Grollman E.F. The teratogenic induction of hypertension. J Clin Invest 1962, 41:710-714.
40. Saksena S.K., Lau I.F. Effects of cadmium chloride on testicular steroidogenesis and fertility of male rats. Endokrinologie 1979, 74(1):6-12.
41. Sutou S., Yamamoto K., Sendota H., Sugiyama M. Toxicity, fertility, teratogenicity, and dominant lethal tests in rats administered cadmium subchronically. II. Fertility, teratogenicity, and dominant lethal tests. Ecotoxicol Environ Saf 1980, 4(1):51-56.
42. Paksy K., Varga B., Lazar P. Effect of cadmium on female fertility, pregnancy and postnatal development in the rat. Acta Physiol Hung 1996, 84(2):119-130.
43. Saksena S.K. Cadmium: its effects on ovulation, egg transport and pregnancy in the rabbit. Contraception 1982, 26(2):181-192.
44. Salvatori F., Talassi C.B., Salzgeber S.A., Spinosa H.S., Bernardi M.M. Embryotoxic and long-term effects of cadmium exposure during embryogenesis in rats. Neurotoxicol Teratol 2004, 26(5):673-680.
45. Padmanabhan R. The effect of cadmium on placental structure and its relation to fetal malformations in the mouse. Z Mikrosk Anat Forsch 1986, 100(3):419-427.
46. Padmanabhan R., Hameed M.S. Exencephaly and axial skeletal dysmorphogenesis induced by maternal exposure to cadmium in the mouse. J Craniofac Genet Dev Biol 1986, 6(3):245-258.
47. Baranski B., Stetkiewicz I., Sitarek K., Szymczak W. Effects of oral, subchronic cadmium administration on fertility, prenatal and postnatal progeny development in rats. Arch Toxicol 1983, 54(4):297-302.
48. Lu S.Y., Liao J.W., Kuo M.L., Wang S.C., Hwang J.S., Ueng T.H. Endocrine-disrupting activity in carbendazim-induced reproductive and developmental toxicity in rats. J Toxicol Environ Health A 2004, 67(19):1501-1515.
49. Morinaga H., Yanase T., Nomura M., Okabe T., Goto K., Harada N., et al. A benzimidazole fungicide, benomyl, and its metabolite, carbendazim, induce aromatase activity in a human ovarian granulose-like tumor cell line (KGN). Endocrinology 2004, 145(4):1860-1869.
50. Gray L.E., Ostby J., Linder R., Goldman J., Rehnberg G., Cooper R. Carbendazim-induced alterations of reproductive development and function in the rat and hamster. Fundam Appl Toxicol 1990, 15(2):281-297.
51. Rajeswary S., Kumaran B., Ilangovan R., Yuvaraj S., Sridhar M., Venkataraman P., et al. Modulation of antioxidant defense system by the environmental fungicide carbendazim in Leydig cells of rats. Reprod Toxicol 2007, 24(3-4):371-380.
52. Carter S.D., Hess R.A., Laskey J.W. The fungicide methyl 2-benzimidazole carbamate causes infertility in male Sprague-Dawley rats. Biol Reprod 1987, 37(3):709-717.
53. Jeffay S.C., Libbus B.L., Barbee R.R., Perreault S.D. Acute exposure of female hamsters to carbendazim (MBC) during meiosis results in aneuploid oocytes with subsequent arrest of embryonic cleavage and implantation. Reprod Toxicol 1996, 10(3):183-189.
54. Janardhan A., Sattur P.B., Sisodia P. Teratogenicity of methyl benzimidazole carbamate in rats and rabbits. Bull Environ Contam Toxicol 1984, 33(3):257-263.
55. Sitarek K. Embryolethal and teratogenic effects of carbendazim in rats. Teratog Carcinog Mutagen 2001, 21(5):335-340.
56. Glatt H., Meinl W. Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of sulfotransferases and acetyltransferases in nitrofen mutagenicity. Carcinogenesis 2004, 25(5):779-786.
57. Noble B.R., Babiuk R.P., Clugston R.D., Underhill T.M., Sun H., Kawaguchi R., et al. Mechanisms of action of the congenital diaphragmatic hernia-inducing teratogen nitrofen. Am J Physiol Lung Cell Mol Physiol 2007, 293(4):L1079-L1087.
58. Gallot D., Marceau G., Coste K., Hadden H., Robert-Gnansia E., Laurichesse H., et al. Congenital diaphragmatic hernia: a retinoid-signaling pathway disruption during lung development?. Birth Defects Res A Clin Mol Teratol 2005, 73(8):523-531.
59. O'Hara G.P., Chan P.K., Harris J.C., Burke S.S., Smith J.M., Hayes A.W. The effect of nitrofen [4-(2,4-dichlorophenoxy)nitrobenzene] on the reproductive performance of male rats. Toxicology 1983, 28(4):323-333.
60. Gray L.E., Kavlock R.J., Chernoff N., Ostby J., Ferrell J. Postnatal developmental alterations following prenatal exposure to the herbicide 2,4-dichlorophenyl-p-nitrophenyl ether: a dose response evaluation in the mouse. Toxicol Appl Pharmacol 1983, 67(1):1-14.
61. IPCS. Pesticide resitues in food - 1983. Sponsored jointly FAO and WHO. Evaluations 1983, Nitrofen. Available from: [cited February 2010]. http://www.inchem.org/documents/jmpr/jmpmono/v83pr32.htm.
62. Ostby J.S., Gray L.E., Kavlock R.J., Ferrell J.M. The postnatal effects of prenatal exposure to low doses of nitrofen (2,4-dichlorophenyl-p-nitrophenyl ether) in Sprague-Dawley rats. Toxicology 1985, 34(4):285-297.
63. Manson J.M. Mechanism of nitrofen teratogenesis. Environ Health Perspect 1986, 70:137-147.
64. Hsu C.H., Stedeford T., Okochi-Takada E., Ushijima T., Noguchi H., Muro-Cacho C., et al. Framework analysis for the carcinogenic mode of action of nitrobenzene. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2007, 25(2):155-184.
65. Dodd D.E., Fowler E.H., Snellings W.M., Pritts I.M., Tyl R.W., Lyon J.P., et al. Reproduction and fertility evaluations in CD rats following nitrobenzene inhalation. Fundam Appl Toxicol 1987, 8(4):493-505.
66. Kawashima K., Usami M., Sakemi K., Ohno Y. Studies on the establishment of appropriate spermatogenic endpoints for male fertility disturbance in rodent induced by drugs and chemicals. I. Nitrobenzene. J Toxicol Sci 1995, 20(1):15-22.
67. Mitsumori K., Kodama Y., Uchida O., Takada K., Saito M., Naito K., et al. Confirmation study, using nitrobenzene, of the combined repeat dose and reproductive/developmental toxicity test protocol proposed by the organization for economic cooperation and development (OECD). J Toxicol Sci 1994, 19(3):141-149.
68. Tyl R.W., France K.A., Fisher L.C., Dodd D.E., Pritts I.M., Lyon J.P., et al. Development toxicity evaluation of inhaled nitrobenzene in CD rats. Fundam Appl Toxicol 1987, 8(4):482-492.
69. Registry AAfTSaD. Toxicological profile for nitrobenzene. U S Public Health Service. December 1990.
70. Gray L.E., Ostby J.S., Kelce W.R. Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rat. Toxicol Appl Pharmacol 1994, 129(1):46-52.
71. Kojima H., Katsura E., Takeuchi S., Niiyama K., Kobayashi K. Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. Environ Health Perspect 2004, 112(5):524-531.
72. Matsuura I., Saitoh T., Ashina M., Wako Y., Iwata H., Toyota N., et al. Evaluation of a two-generation reproduction toxicity study adding endpoints to detect endocrine disrupting activity using vinclozolin. J Toxicol Sci 2005, 30(Spec No.):163-188.
73. Anway M.D., Memon M.A., Uzumcu M., Skinner M.K. Transgenerational effect of the endocrine disruptor vinclozolin on male spermatogenesis. J Androl 2006, 27(6):868-879.
74. Uzumcu M., Suzuki H., Skinner M.K. Effect of the anti-androgenic endocrine disruptor vinclozolin on embryonic testis cord formation and postnatal testis development and function. Reprod Toxicol 2004, 18(6):765-774.
75. Schneider S., Kaufmann W., Buesen R., van Ravenzwaay B. Vinclozolin - the lack of a transgenerational effect after oral maternal exposure during organogenesis. Reprod Toxicol 2008, 25(3):352-360.
76. Wolf C.J., LeBlanc G.A., Ostby J.S., Gray L.E. Characterization of the period of sensitivity of fetal male sexual development to vinclozolin. Toxicol Sci 2000, 55(1):152-161.
77. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007, 24(2):139-177.
78. Goodman J.E., McConnell E.E., Sipes I.G., Witorsch R.J., Slayton T.M., Yu C.J., et al. An updated weight of the evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Crit Rev Toxicol 2006, 36(5):387-457.
79. Kitamura S., Suzuki T., Sanoh S., Kohta R., Jinno N., Sugihara K., et al. Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds. Toxicol Sci 2005, 84(2):249-259.
80. Kruger T., Long M., Bonefeld-Jorgensen E.C. Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor. Toxicology 2008, 246(2-3):112-123.
81. Sohoni P., Sumpter J.P. Several environmental oestrogens are also anti-androgens. J Endocrinol 1998, 158(3):327-339.
82. Sun H., Xu L.C., Chen J.F., Song L., Wang X.R. Effect of bisphenol A, tetrachlorobisphenol A and pentachlorophenol on the transcriptional activities of androgen receptor-mediated reporter gene. Food Chem Toxicol 2006, 44(11):1916-1921.
83. Xu L.C., Sun H., Chen J.F., Bian Q., Qian J., Song L., et al. Evaluation of androgen receptor transcriptional activities of bisphenol A, octylphenol and nonylphenol in vitro. Toxicology 2005, 216(2-3):197-203.
84. Pacchierotti F., Ranaldi R., Eichenlaub-Ritter U., Attia S., Adler I.D. Evaluation of aneugenic effects of bisphenol A in somatic and germ cells of the mouse. Mutat Res 2008, 651(1-2):64-70.
85. Hunt P.A., Koehler K.E., Susiarjo M., Hodges C.A., Ilagan A., Voigt R.C., et al. Bisphenol a exposure causes meiotic aneuploidy in the female mouse. Curr Biol 2003, 13(7):546-553.
86. Eichenlaub-Ritter U., Vogt E., Cukurcam S., Sun F., Pacchierotti F., Parry J. Exposure of mouse oocytes to bisphenol A causes meiotic arrest but not aneuploidy. Mutat Res 2008, 651(1-2):82-92.
87. Tyl R.W., Myers C.B., Marr M.C., Sloan C.S., Castillo N.P., Veselica M.M., et al. Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice. Toxicol Sci 2008, 104(2):362-384.
88. Tyl R.W., Myers C.B., Marr M.C., Thomas B.F., Keimowitz A.R., Brine D.R., et al. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol Sci 2002, 68(1):121-146.
89. Takahashi O., Oishi S. Testicular toxicity of dietary 2,2-bis(4-hydroxyphenyl)propane (bisphenol A) in F344 rats. Arch Toxicol 2001, 75(1):42-51.
90. Salian S., Doshi T., Vanage G. Perinatal exposure of rats to Bisphenol A affects the fertility of male offspring. Life Sci 2009, 85(21-22):742-752.
91. Al-Hiyasat A.S., Darmani H., Elbetieha A.M. Effects of bisphenol A on adult male mouse fertility. Eur J Oral Sci 2002, 110(2):163-167.
92. Salian S., Doshi T., Vanage G. Neonatal exposure of male rats to Bisphenol A impairs fertility and expression of sertoli cell junctional proteins in the testis. Toxicology 2009, 265(1-2):56-67.
93. Yamasaki K., Sawaki M., Noda S., Imatanaka N., Takatsuki M. Subacute oral toxicity study of ethynylestradiol and bisphenol A, based on the draft protocol for the " Enhanced OECD Test Guideline no. 407" Arch Toxicol 2002, 76(2):65-74.
94. Kim J.C., Shin H.C., Cha S.W., Koh W.S., Chung M.K., Han S.S. Evaluation of developmental toxicity in rats exposed to the environmental estrogen bisphenol A during pregnancy. Life Sci 2001, 69(22):2611-2625.
95. Morrissey R.E., George J.D., Price C.J., Tyl R.W., Marr M.C., Kimmel C.A. The developmental toxicity of bisphenol A in rats and mice. Fundam Appl Toxicol 1987, 8(4):571-582.
96. Schonfelder G., Friedrich K., Paul M., Chahoud I. Developmental effects of prenatal exposure to bisphenol a on the uterus of rat offspring. Neoplasia 2004, 6(5):584-594.
97. Guidance document on mammalian reproductive toxicity testing and assessment. Environment Directorate. Joint meeting of the Chemicals Committee and the Working Party on chemicals, pesticides and biotechnology. 2008;16:1-88.
98. Spielmann H., Vogel R. REACH testing requirements must not be driven by reproductive toxicity testing. Altern Lab Anim 2006, 34(4):365-366.
99. Hengstler J.G., Van der Burg B., Steinberg P., Oesch F. Interspecies differences in cancer susceptibility and toxicity. Drug Metab Rev 1999, 31(4):917-970.
100. Guengerich F.P., MacDonald J.S. Applying mechanisms of chemical toxicity to predict drug safety. Chem Res Toxicol 2007, 20(3):344-369.
101. Spielmann H. Developmental and reproductive toxicity testing: animal studies are not predictive for humans. Altern Lab Anim 2008, 36(6):715-716.
102. Watanabe T., Iwase T. Developmental and dysmorphogenic effects of glufosinate ammonium on mouse embryos in culture. Teratog Carcinog Mutagen 1996, 16(6):287-299.
103. Watanabe T. Apoptosis induced by glufosinate ammonium in the neuroepithelium of developing mouse embryos in culture. Neurosci Lett 1997, 222(1):17-20.
104. Iwase T., Watanabe T. Glufosinate induced morphological defects in cultured rat embryos. Teratology 1996, 54(4):A12-A13.
105. Haberle J., Gorg B., Toutain A., Rutsch F., Benoist J.F., Gelot A., et al. Inborn error of amino acid synthesis: human glutamine synthetase deficiency. J Inherit Metab Dis 2006, 29(2-3):352-358.
106. Chi M.M., Hoehn A., Moley K.H. Metabolic changes in the glucose-induced apoptotic blastocyst suggest alterations in mitochondrial physiology. Am J Physiol Endocrinol Metab 2002, 283(2):E226-E232.
107. Lane M., Gardner D.K. Nonessential amino acids and glutamine decrease the time of the first three cleavage divisions and increase compaction of mouse zygotes in vitro. J Assist Reprod Genet 1997, 14(7):398-403.
108. Hardin B.D. Reproductive toxicity of the glycol ethers. Toxicology 1983, 27(2):91-102.
109. Barone F., Aguanno S., D'Agostino A. Modulation of MAA-induced apoptosis in male germ cells: role of Sertoli cell P/Q-type calcium channels. Reprod Biol Endocrinol 2005, 3:13.
110. Eikel D., Lampen A., Nau H. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Chem Res Toxicol 2006, 19(2):272-278.
111. Beyersmann D., Hartwig A. Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch Toxicol 2008, 82(8):493-512.
112. Martinez-Campa C., Alonso-Gonzalez C., Mediavilla M.D., Cos S., Gonzalez A., Ramos S., et al. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium. J Pineal Res 2006, 40(4):291-296.
113. Wilson V.S., Bobseine K., Gray L.E. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. Toxicol Sci 2004, 81(1):69-77.
114. Stoica A., Katzenellenbogen B.S., Martin M.B. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 2000, 14(4):545-553.
115. Rider C.V., Hartig P.C., Cardon M.C., Wilson V.S. Comparison of chemical binding to recombinant fathead minnow and human estrogen receptors alpha in whole cell and cell-free binding assays. Environ Toxicol Chem 2009, 28(10):2175-2181.
116. Akerib D.S., Barish B., Cowen D.F., Eigen G., Stroynowski R., Urheim J., et al. Measurement of the inclusive B* cross section above the Upsilon (4S). Phys Rev Lett 1991, 67(13):1692-1695.
117. Garcia-Morales P., Saceda M., Kenney N., Kim N., Salomon D.S., Gottardis M.M., et al. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem 1994, 269(24):16896-16901.
118. Zang Y., Odwin-Dacosta S., Yager J.D. Effects of cadmium on estrogen receptor mediated signaling and estrogen induced DNA synthesis in T47D human breast cancer cells. Toxicol Lett 2009, 184(2):134-138.
119. Denier X., Couteau J., Baudrimont M., Hill E.M., Rotchell J., Minier C. In vitro study of the effects of cadmium on the activation of the estrogen response element using the YES screen. Mar Environ Res 2008, 66(1):108-110.
120. Denier X., Hill E.M., Rotchell J., Minier C. Estrogenic activity of cadmium, copper and zinc in the yeast estrogen screen. Toxicol In Vitro 2009, 23(4):569-573.
121. Silva E., Lopez-Espinosa M.J., Molina-Molina J.M., Fernandez M., Olea N., Kortenkamp A. Lack of activity of cadmium in in vitro estrogenicity assays. Toxicol Appl Pharmacol 2006, 216(1):20-28.
122. Johnson M.D., Kenney N., Stoica A., Hilakivi-Clarke L., Singh B., Chepko G., et al. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 2003, 9(8):1081-1084.
123. Thevenod F. Cadmium and cellular signaling cascades: to be or not to be?. Toxicol Appl Pharmacol 2009, 238(3):221-239.
124. Waisberg M., Joseph P., Hale B., Beyersmann D. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 2003, 192(2-3):95-117.
125. Gupta K., Bishop J., Peck A., Brown J., Wilson L., Panda D. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin. Biochemistry 2004, 43(21):6645-6655.
126. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 1993, 101(5):378-384.
127. Yamada T., Sumida K., Saito K., Ueda S., Yabushita S., Sukata T., et al. Functional genomics may allow accurate categorization of the benzimidazole fungicide benomyl: lack of ability to act via steroid-receptor-mediated mechanisms. Toxicol Appl Pharmacol 2005, 205(1):11-30.
128. Can A., Albertini D.F. Stage specific effects of carbendazim (MBC) on meiotic cell cycle progression in mouse oocytes. Mol Reprod Dev 1997, 46(3):351-362.
129. Can A., Albertini D.F. M-phase specific centrosome-microtubule alterations induced by the fungicide MBC in human granulosa cells. Mutat Res 1997, 373(1):139-151.
130. Okubo T., Yokoyama Y., Kano K., Soya Y., Kano I. Estimation of estrogenic and antiestrogenic activities of selected pesticides by MCF-7 cell proliferation assay. Arch Environ Contam Toxicol 2004, 46(4):445-453.
131. Tomura A., Goto K., Morinaga H., Nomura M., Okabe T., Yanase T., et al. The subnuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein. J Biol Chem 2001, 276(30):28395-28401.
132. ATSDR. Toxicological profile for nitrobenzene. Agency for Toxic substances and Disease Registry U S Public Health Service, December 1990.
133. Kelce W.R., Monosson E., Gamcsik M.P., Laws S.C., Gray L.E. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol 1994, 126(2):276-285.
134. Bovee T.F., Lommerse J.P., Peijnenburg A.A., Fernandes E.A., Nielen M.W. A new highly androgen specific yeast biosensor, enabling optimisation of (Q)SAR model approaches. J Steroid Biochem Mol Biol 2008, 108(1-2):121-131.
135. Bovee T.F., Helsdingen R.J., Hamers A.R., van Duursen M.B., Nielen M.W., Hoogenboom R.L. A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonists. Anal Bioanal Chem 2007, 389(5):1549-1558.
136. Freyberger A., Hartmann E., Krotlinger F. Evaluation of the rodent Hershberger bioassay using three reference (anti)androgens. Arh Hig Rada Toksikol 2005, 56(2):131-139.
137. Kang I.H., Kim H.S., Shin J.H., Kim T.S., Moon H.J., Kim I.Y., et al. Comparison of anti-androgenic activity of flutamide, vinclozolin, procymidone, linuron, and p, p′-DDE in rodent 10-day Hershberger assay. Toxicology 2004, 199(2-3):145-159.
138. Shin J.H., Moon H.J., Kim T.S., Kang I.H., Ki H.Y., Choi K.S., et al. Repeated 28-day oral toxicity study of vinclozolin in rats based on the draft protocol for the " Enhanced OECD Test Guideline No. 407" to detect endocrine effects. Arch Toxicol 2006, 80(9):547-554.
139. Kelce W.R., Lambright C.R., Gray L.E., Roberts K.P. Vinclozolin and p,p′-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism. Toxicol Appl Pharmacol 1997, 142(1):192-200.
140. Molina-Molina J.M., Hillenweck A., Jouanin I., Zalko D., Cravedi J.P., Fernandez M.F., et al. Steroid receptor profiling of vinclozolin and its primary metabolites. Toxicol Appl Pharmacol 2006, 216(1):44-54.
141. Buteau-Lozano H., Velasco G., Cristofari M., Balaguer P., Perrot-Applanat M. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism. J Endocrinol 2008, 196(2):399-412.
142. EU. 4,4′-Isopropylidenediphenol (bisphenol A). Updated Risk assessment report. Luxemburg: Office for Official Publications of the European Communities; 2008.
143. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 2009, 30(1):75-95.
144. Richter C.A., Birnbaum L.S., Farabollini F., Newbold R.R., Rubin B.S., Talsness C.E., et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 2007, 24(2):199-224.
145. Goodman J.E., Witorsch R.J., McConnell E.E., Sipes I.G., Slayton T.M., Yu C.J., et al. Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Crit Rev Toxicol 2009, 39(1):1-75.
146. EFSA Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food on a request from the commission related to 2,2-bis(4-hydroxyphenyl)propane (Bisphenol A). EFSA J 2006, 428:1-75.
147. EFSA Toxicokinetics of bisphenol A: scientific opinion of the panel on food additives, flavourings, processing aids and materials in contact with food (AFC). EFSA J 2008, 759:1-10.
148. Chapin R.E., Adams J., Boekelheide K., Gray L.E., Hayward S.W., Lees P.S., et al. NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res B Dev Reprod Toxicol 2008, 83(3):157-395.
149. Willhite C.C., Ball G.L., McLellan C.J. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration. J Toxicol Environ Health B Crit Rev 2008, 11(2):69-146.
150. EU(2003). European Union Risk Assessment Report. Bisphenol A, CAS No: 80-05-7. Institute for Health and Consumer Protection. European Chemicals Bureau, European commission Joint Research Centre. 3rd Priority List. Luxembur: Office for Official Publications of the European Communities; 2003.
151. Kim H.S., Han S.Y., Kim T.S., Kwack S.J., Lee R.D., Kim I.Y., et al. No androgenic/anti-androgenic effects of bisphenol-A in Hershberger assay using immature castrated rats. Toxicol Lett 2002, 135(1-2):111-123.
152. Nishino T., Wedel T., Schmitt O., Schonfelder M., Hirtreiter C., Schulz T., et al. The xenoestrogen bisphenol A in the Hershberger assay: androgen receptor regulation and morphometrical reactions indicate no major effects. J Steroid Biochem Mol Biol 2006, 98(2-3):155-163.
153. Pottenger L.H., Domoradzki J.Y., Markham D.A., Hansen S.C., Cagen S.Z., Waechter J.M. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol Sci 2000, 54(1):3-18.
154. Susiarjo M., Hassold T.J., Freeman E., Hunt P.A., Bisphenol A exposure in utero disrupts early oogenesis in the mouse. PLoS Genet 2007, 3(1):e5.
155. Pacchierotti F., Ranaldi R. Mechanisms and risk of chemically induced aneuploidy in mammalian germ cells. Curr Pharm Des 2006, 12(12):1489-1504.
156. Mlynarcikova A., Nagyova E., Fickova M., Scsukova S. Effects of selected endocrine disruptors on meiotic maturation, cumulus expansion, synthesis of hyaluronan and progesterone by porcine oocyte-cumulus complexes. Toxicol In Vitro 2009, 23(3):371-377.
157. Lenie S., Cortvrindt R., Eichenlaub-Ritter U., Smitz J. Continuous exposure to bisphenol A during in vitro follicular development induces meiotic abnormalities. Mutat Res 2008, 651(1-2):71-81.
158. Can A., Semiz O., Cinar O. Bisphenol-A induces cell cycle delay and alters centrosome and spindle microtubular organization in oocytes during meiosis. Mol Hum Reprod 2005, 11(6):389-396.
159. Volkel W., Colnot T., Csanady G.A., Filser J.G., Dekant W. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol 2002, 15(10):1281-1287.
160. Beronius A., Ruden C., Hakansson H., Hanberg A. Risk to all or none? A comparative analysis of controversies in the health risk assessment of Bisphenol A. Reprod Toxicol 2010, 29(2):132-146.
161. Bitsch A., Jacobi S., Melber C., Wahnschaffe U., Simetska N., Mangelsdorf I. REPDOSE: a database on repeated dose toxicity studies of commercial chemicals - a multifunctional tool. Regul Toxicol Pharmacol 2006, 46(3):202-210.
162. Janer G., Hakkert B.C., Piersma A.H., Vermeire T., Slob W. A retrospective analysis of the added value of the rat two-generation reproductive toxicity study versus the rat subchronic toxicity study. Reprod Toxicol 2007, 24(1):103-113.
163. Dent M.P. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility. Regul Toxicol Pharmacol 2007, 48(3):241-258.
164. Hettwer M., Fernandes M.A., Iken M., Ott M., Steinberg P., Nau H. Metabolic activation capacity by primary hepatocytes expands the applicability of the embryonic stem cell test as alternative to experimental animal testing. Reprod Toxicol 2010, 30(1):113-120.
165. Verwei M., van Burgsteden J.A., Krul C.A., van de Sandt J.J., Freidig A.P. Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling. Toxicol Lett 2006, 165(1):79-87.